These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
83 related articles for article (PubMed ID: 25420270)
1. Quantitative analysis of drug-induced complement-mediated cytotoxic effect on single tumor cells using atomic force microscopy and fluorescence microscopy. Li M; Liu L; Xi N; Wang Y; Xiao X; Zhang W IEEE Trans Nanobioscience; 2015 Jan; 14(1):84-94. PubMed ID: 25420270 [TBL] [Abstract][Full Text] [Related]
2. Imaging and measuring the rituximab-induced changes of mechanical properties in B-lymphoma cells using atomic force microscopy. Li M; Liu L; Xi N; Wang Y; Dong Z; Tabata O; Xiao X; Zhang W Biochem Biophys Res Commun; 2011 Jan; 404(2):689-94. PubMed ID: 21156157 [TBL] [Abstract][Full Text] [Related]
3. Atomic force microscopy study of the antigen-antibody binding force on patient cancer cells based on ROR1 fluorescence recognition. Li M; Xiao X; Liu L; Xi N; Wang Y; Dong Z; Zhang W J Mol Recognit; 2013 Sep; 26(9):432-8. PubMed ID: 23836471 [TBL] [Abstract][Full Text] [Related]
4. Nanoscale Quantifying the Effects of Targeted Drug on Chemotherapy in Lymphoma Treatment Using Atomic Force Microscopy. Li M; Xiao X; Liu L; Xi N; Wang Y IEEE Trans Biomed Eng; 2016 Oct; 63(10):2187-99. PubMed ID: 26731520 [TBL] [Abstract][Full Text] [Related]
5. Imaging and measuring the molecular force of lymphoma pathological cells using atomic force microscopy. Li M; Xiao X; Liu L; Xi N; Wang Y; Dong Z; Zhang W Scanning; 2013; 35(1):40-6. PubMed ID: 22890585 [TBL] [Abstract][Full Text] [Related]
6. CMC-544 (inotuzumab ozogamicin), an anti-CD22 immuno-conjugate of calicheamicin, alters the levels of target molecules of malignant B-cells. Takeshita A; Yamakage N; Shinjo K; Ono T; Hirano I; Nakamura S; Shigeno K; Tobita T; Maekawa M; Kiyoi H; Naoe T; Ohnishi K; Sugimoto Y; Ohno R Leukemia; 2009 Jul; 23(7):1329-36. PubMed ID: 19369961 [TBL] [Abstract][Full Text] [Related]
7. Nanoscale imaging and mechanical analysis of Fc receptor-mediated macrophage phagocytosis against cancer cells. Li M; Liu L; Xi N; Wang Y; Xiao X; Zhang W Langmuir; 2014 Feb; 30(6):1609-21. PubMed ID: 24495237 [TBL] [Abstract][Full Text] [Related]
8. AFM analysis of the multiple types of molecular interactions involved in rituximab lymphoma therapy on patient tumor cells and NK cells. Li M; Xiao X; Zhang W; Liu L; Xi N; Wang Y Cell Immunol; 2014 Aug; 290(2):233-44. PubMed ID: 25117605 [TBL] [Abstract][Full Text] [Related]
9. Rapid recognition and functional analysis of membrane proteins on human cancer cells using atomic force microscopy. Li M; Xiao X; Liu L; Xi N; Wang Y J Immunol Methods; 2016 Sep; 436():41-9. PubMed ID: 27374866 [TBL] [Abstract][Full Text] [Related]
10. Detecting CD20-rituximab specific interactions on lymphoma cells using atomic force microscopy. Li M; Liu L; Xi N; Wang Y; Dong Z; Li G; Xiao X; Zhang W Sci China Life Sci; 2010 Oct; 53(10):1189-95. PubMed ID: 20953941 [TBL] [Abstract][Full Text] [Related]
11. Nanoscale mapping and organization analysis of target proteins on cancer cells from B-cell lymphoma patients. Li M; Xiao X; Liu L; Xi N; Wang Y; Dong Z; Zhang W Exp Cell Res; 2013 Nov; 319(18):2812-21. PubMed ID: 23896027 [TBL] [Abstract][Full Text] [Related]
12. Antitumor efficacy of a combination of CMC-544 (inotuzumab ozogamicin), a CD22-targeted cytotoxic immunoconjugate of calicheamicin, and rituximab against non-Hodgkin's B-cell lymphoma. DiJoseph JF; Dougher MM; Kalyandrug LB; Armellino DC; Boghaert ER; Hamann PR; Moran JK; Damle NK Clin Cancer Res; 2006 Jan; 12(1):242-9. PubMed ID: 16397048 [TBL] [Abstract][Full Text] [Related]
13. Effect of alemtuzumab on neoplastic B cells. Golay J; Manganini M; Rambaldi A; Introna M Haematologica; 2004 Dec; 89(12):1476-83. PubMed ID: 15590398 [TBL] [Abstract][Full Text] [Related]
14. Anti-CD20 antibody (IDEC-C2B8, rituximab) enhances efficacy of cytotoxic drugs on neoplastic lymphocytes in vitro: role of cytokines, complement, and caspases. Chow KU; Sommerlad WD; Boehrer S; Schneider B; Seipelt G; Rummel MJ; Hoelzer D; Mitrou PS; Weidmann E Haematologica; 2002 Jan; 87(1):33-43. PubMed ID: 11801463 [TBL] [Abstract][Full Text] [Related]
15. Imaging and measuring the biophysical properties of Fc gamma receptors on single macrophages using atomic force microscopy. Li M; Liu L; Xi N; Wang Y; Xiao X; Zhang W Biochem Biophys Res Commun; 2013 Sep; 438(4):709-14. PubMed ID: 23916706 [TBL] [Abstract][Full Text] [Related]
16. NK cell-mediated lysis is essential to kill Epstein-Barr virus transformed lymphoblastoid B cells when using rituximab. Markasz L; Vanherberghen B; Flaberg E; Otvös R; Stuber G; Gustafsson Jernberg A; Olah E; Skribek H; Szekely L Biomed Pharmacother; 2009 Jul; 63(6):413-20. PubMed ID: 18834693 [TBL] [Abstract][Full Text] [Related]
17. Rituximab-mediated antibody-dependent cellular cytotoxicity against neoplastic B cells is stimulated strongly by interleukin-2. Golay J; Manganini M; Facchinetti V; Gramigna R; Broady R; Borleri G; Rambaldi A; Introna M Haematologica; 2003 Sep; 88(9):1002-12. PubMed ID: 12969808 [TBL] [Abstract][Full Text] [Related]
18. Atomic force microscopy: a nanoscopic window on the cell surface. Müller DJ; Dufrêne YF Trends Cell Biol; 2011 Aug; 21(8):461-9. PubMed ID: 21664134 [TBL] [Abstract][Full Text] [Related]
19. Intratumoral but not systemic delivery of CpG oligodeoxynucleotide augments the efficacy of anti-CD20 monoclonal antibody therapy against B cell lymphoma. Betting DJ; Yamada RE; Kafi K; Said J; van Rooijen N; Timmerman JM J Immunother; 2009; 32(6):622-31. PubMed ID: 19483647 [TBL] [Abstract][Full Text] [Related]
20. Identifying dynamic membrane structures with atomic-force microscopy and confocal imaging. Timmel T; Schuelke M; Spuler S Microsc Microanal; 2014 Apr; 20(2):514-20. PubMed ID: 24524258 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]